SLC25A13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.34550004471379E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.39150000036892E-07 |
Normal-vs-Stage2 |
3.36629999997395E-06 |
Normal-vs-Stage3 |
8.53750403706499E-11 |
Normal-vs-Stage4 |
6.62479999746779E-08 |
Stage1-vs-Stage2 |
2.880000E-01 |
Stage1-vs-Stage3 |
3.563300E-03 |
Stage1-vs-Stage4 |
3.880100E-02 |
Stage2-vs-Stage3 |
3.128200E-01 |
Stage2-vs-Stage4 |
4.389800E-01 |
Stage3-vs-Stage4 |
9.607000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.65519997707975E-09 |
Normal-vs-AfricanAmerican |
6.22720000009735E-07 |
Normal-vs-Asian |
3.715700E-02 |
Caucasian-vs-AfricanAmerican |
5.935800E-01 |
Caucasian-vs-Asian |
8.216200E-01 |
AfricanAmerican-vs-Asian |
6.675200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.94289029309402E-14 |
Normal-vs-Female |
1.425920E-04 |
Male-vs-Female |
2.986700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.629810E-04 |
Normal-vs-Age(41-60Yrs) |
6.63929999866752E-09 |
Normal-vs-Age(61-80Yrs) |
5.65790003737021E-09 |
Normal-vs-Age(81-100Yrs) |
1.54025999999918E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.710000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.037400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.725400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.057800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.464800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.681600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.280600E-01 |
Normal-vs-Grade 2 |
2.85990000004066E-06 |
Normal-vs-Grade 3 |
1.7133999996588E-08 |
Normal-vs-Grade 4 |
1.65056857071022E-12 |
Grade 1-vs-Grade 2 |
3.932600E-01 |
Grade 1-vs-Grade 3 |
1.708800E-01 |
Grade 1-vs-Grade 4 |
1.636870E-03 |
Grade 2-vs-Grade 3 |
1.541770E-01 |
Grade 2-vs-Grade 4 |
4.15220000005156E-06 |
Grade 3-vs-Grade 4 |
9.574600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.954880E-04 |
Normal-vs-ccB subtype |
2.07780459504647E-11 |
ccA subtype-vs-ccB subtype |
8.54069999944862E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.9318999944804E-08 |
Normal-vs-N1 |
2.767400E-04 |
N0-vs-N1 |
3.349400E-01 |
|
|